Suchergebnisse - "Stagno, Fabio"

PubPharm (25)

1

Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival

enthalten in: Leukemia research | 2014

von Breccia, M. | Luciano, L. | Latagliata, R. | +33

CommentIn: Leuk Res. 2014 Oct;38(10):1156-7. - PMID 25113280

2

IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation

enthalten in: Carcinogenesis | 2014

von Massimino, M. | Consoli, M. | Mesuraca, M. | +12

3

Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era

enthalten in: American journal of hematology | 2014

von Malagola, M. | Breccia, M. | Skert, C. | +29

4

Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase : a retrospective study

enthalten in: Drugs & aging | 2013

von Latagliata, R. | Ferrero, D. | Iurlo, A. | +32

5

Suppression of survivin induced by a BCR-ABL/JAK2/STAT3 pathway sensitizes imatinib-resistant CML cells to different cytotoxic drugs

enthalten in: Molecular cancer therapeutics | 2013

von Stella, S. | Tirrò, E. | Conte, E. | +4

6

Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia

enthalten in: Blood | 2013

von Russo, D. | Martinelli, G. | Malagola, M. | +23

ErratumIn: Blood. 2014 May 1;123(18):2902 Bergamaschi, Michela [corrected to Bergamaschi, Micaela]

7

SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation

enthalten in: BMC cancer | 2013

von Giallongo, C. | La Cava, P. | Tibullo, D. | +8

8

Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells

enthalten in: Current pharmaceutical design | 2013

von Tibullo, D. | Barbagallo, I. | Giallongo, C. | +7

9

Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia

enthalten in: Annals of hematology | 2013

von Tiribelli, M. | Latagliata, R. | Luciano, L. | +17

10

Personalized strategies for CML patients considering discontinuation of tyrosine kinase inhibitors treatment

enthalten in: Leukemia research | 2012

von Stagno, F. | Vigneri, P. | Cupri, A. | +2

CommentOn: Leuk Res. 2012 Jun;36(6):689-93. - PMID 22398220